Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Dyslipidemias in Kidney Disease
Covic, Kanbay, Lerma
Editore
Springer
Anno
2014
Pagine
312
ISBN
9781493905140
103,00 €
- Comprehensive resource that fills a significant knowledge gap
- Features the latest clinical evidence and management guidance
- Chapters authored by leaders in the field
Dyslipidemia in chronic kidney disease is a common clinical problem and growing in prevalence. With the recent publication of clinical practice guidelines on the management of lipid related disorders in patients affected by chronic kidney disease, an up-to-date and comprehensive resource of evidence-based literature is needed. Dyslipidemias in Kidney Disease captures the growing body of information on this subject matter. This book presents the latest clinical evidence and management guidance for patients of various demographics and stages of chronic kidney disease. Written for the nephrologist community, as well as cardiologists and general practitioners, this guide will provide practical knowledge and fill a much needed void in the literature.
Contents
1 Epidemiology/Prevalence of Dyslipidemia in the General
Population and in Patients with Chronic Kidney Disease ................... 1
Tevfi k Ecder
2 Lipid Nephrotoxicity: New Concept for an Old Disease ..................... 9
Xiong Zhong Ruan, Zac Varghese, and John Moorhead
3 Hyperlipidemia as a Risk Factor for Progression
of CKD in Nondiabetics .......................................................................... 27
Agata Kujawa-Szewieczek, Grzegorz Piecha,
and Andrzej Więcek
4 How Lipid-Lowering Agents Work:
The Good, the Bad, and the Ugly........................................................... 45
Faruk Turgut, Ihsan Ustun, and Cumali Gokce
5 CVD in CKD: Focus on the Dyslipidemia Problem ............................. 67
Theodoros Kassimatis and David Goldsmith
6 The CKD Patient with Dyslipidemia ..................................................... 93
Valentina Batini and Stefano Bianchi
7 Review of Clinical Trials Pertaining to Dyslipidemias in CKD .......... 111
Markus P. Schneider and Kai-Uwe Eckardt
8 Pharmacokinetics of Lipid-Lowering Medications
in Chronic Kidney Disease ..................................................................... 129
Ali Olyaei, Jessica Lassiter, and Edgar V. Lerma
9 Non-statin Therapies for CKD with Dyslipidemia ............................... 153
Istvan Mucsi
10 Dyslipidemia in Dialysis ......................................................................... 179
Yalcin Solak and Halil Zeki Tonbul
11 Dyslipidemia in the Kidney Transplant Patient ................................... 203
Rajan Kantilal Patel and Alan G. Jardine
12 Dyslipidemia in Nephrotic Syndrome ................................................... 213
Minso Kim and Howard Trachtman
13 Dyslipidemias in the Pediatric Chronic Kidney
Disease Patient ......................................................................................... 231
Zeynep Birsin Özçakar and Fatoş Yalçınkaya
14 Dyslipidemias in the Geriatric Chronic Kidney
Disease Patients ....................................................................................... 255
Zeynel Abidin Ozturk and Zekeriya Ulger
15 Apheresis Methods in Hyperlipidemias ................................................ 269
Serdar Sivgin
16 Review of Current Guidelines: National Cholesterol
Education Program and Kidney Disease Outcomes Quality
Initiative as They Apply to CKD with Dyslipidemias .......................... 287
Baris Afsar
Index ................................................................................................................. 301
